Simplex Trading’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Simplex Trading’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3	Closed	-$689	–	8065
2019 Q2	$0	Sell	3 -10	-77%	-$3.35K	﹤0.01%	7998
2019 Q1	$4K	Buy	+13	New	+$4.36K	﹤0.01%	6599
2018 Q3	–	Sell	-2	Closed	–	–	8252
2018 Q2	$0	Sell	2 -5	-71%	-$2.35K	﹤0.01%	8034
2018 Q1	$3K	Sell	7 -3	-30%	-$1.49K	﹤0.01%	5090
2017 Q4	$5K	Buy	+10	New	+$6.59K	﹤0.01%	4585
2017 Q2	–	Sell	-1	Closed	–	–	6972
2017 Q1	$0	Hold	1	–	–	﹤0.01%	6945
2016 Q4	$0	Buy	+1	New	+$812	﹤0.01%	6720
2016 Q3	–	Sell	-4	Closed	-$5.05K	–	6631
2016 Q2	$6K	Buy	+4	New	+$5.14K	﹤0.01%	4138
2016 Q1	–	Hold	0	–	–	–	6426
2015 Q4	–	Hold	0	–	–	–	6322
2015 Q3	–	Sell	-2	Closed	-$3.86K	–	6358
2015 Q2	$3K	Buy	2 +1	+100%	+$3.14K	﹤0.01%	4138
2015 Q1	$2K	Buy	+1	New	+$3.2K	﹤0.01%	4235
2014 Q4	–	Hold	0	–	–	–	4657

Other funds holding FRTX

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's FRTX Position: Q3 2019 in Review

Simplex Trading sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2019, closing a stake of 3 shares — an estimated $689 sold.

Simplex Trading first reported a position in FRTX in Q1 2015 and held it in 10 quarters. The position peaked at $6K in Q2 2016. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2019.

Simplex Trading reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Simplex Trading sold 3 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $689.
Simplex Trading first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q1 2015 and held it in 10 quarters.
Simplex Trading's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $6K in Q2 2016.
17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Simplex Trading's 13F filing for Q3 2019, filed 15 Oct 2019.